Does the media prefer KSPI or LIF?

In the previous week, Life360 had 9 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 11 mentions for Life360 and 2 mentions for Joint Stock Company Kaspi.kz. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Life360's score of 0.44 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Joint Stock Company Kaspi.kz 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, MEDP or LIF?

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 6.01 $451.12M $15.91 33.49 Life360 $489.48M 9.15 $150.83M $1.73 31.96

Is MEDP or LIF more profitable?

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.19% 120.89% 24.79% Life360 28.21% 6.80% 3.65%

Does the media prefer MEDP or LIF?

In the previous week, Life360 had 8 more articles in the media than Medpace. MarketBeat recorded 11 mentions for Life360 and 3 mentions for Medpace. Medpace's average media sentiment score of 0.98 beat Life360's score of 0.44 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, LIF or RTO?

Rentokil Initial has higher revenue and earnings than Life360. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 9.15 $150.83M $1.73 31.96 Rentokil Initial $6.91B 2.09 $470M N/A N/A

Which has preferable valuation and earnings, LIF or GRAB?

Grab has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 9.15 $150.83M $1.73 31.96 Grab $3.37B 4.63 $268M $0.01 380.50

Is LIF or GRAB more profitable?

Life360 has a net margin of 28.21% compared to Grab's net margin of 10.67%. Life360's return on equity of 6.80% beat Grab's return on equity. Company Net Margins Return on Equity Return on Assets Life360 28.21% 6.80% 3.65% Grab 10.67% 5.79% 3.28%

Does the media refer more to LIF or GRAB?

In the previous week, Grab had 1 more articles in the media than Life360. MarketBeat recorded 12 mentions for Grab and 11 mentions for Life360. Grab's average media sentiment score of 0.63 beat Life360's score of 0.44 indicating that Grab is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Grab 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, LIF or TOST?

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 9.15 $150.83M $1.73 31.96 Toast $6.45B 2.24 $342M $0.65 43.02

Is LIF or TOST more profitable?

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Life360 28.21% 6.80% 3.65% Toast 6.39% 20.86% 13.84%

Does the media favor LIF or TOST?

In the previous week, Life360 had 6 more articles in the media than Toast. MarketBeat recorded 11 mentions for Life360 and 5 mentions for Toast. Life360's average media sentiment score of 0.44 beat Toast's score of 0.42 indicating that Life360 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Toast 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Life360 (LIF) Competitors

$55.54 -2.04 (-3.53%)

As of 02:58 PM Eastern

Compare

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

Should you buy Life360 stock or one of its competitors? MarketBeat compares Life360 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Life360 include Joint Stock Company Kaspi.kz (KSPI), Medpace (MEDP), Rentokil Initial (RTO), Grab (GRAB), and Toast (TOST). These companies are all part of the "business services" industry.

How does Life360 compare to Joint Stock Company Kaspi.kz?

Joint Stock Company Kaspi.kz (NASDAQ:KSPI) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Joint Stock Company Kaspi.kz presently has a consensus price target of $96.67, suggesting a potential upside of 11.74%. Life360 has a consensus price target of $64.17, suggesting a potential upside of 16.04%. Given Life360's stronger consensus rating and higher probable upside, analysts clearly believe Life360 is more favorable than Joint Stock Company Kaspi.kz.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint Stock Company Kaspi.kz	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

In the previous week, Life360 had 9 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 11 mentions for Life360 and 2 mentions for Joint Stock Company Kaspi.kz. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Life360's score of 0.44 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Joint Stock Company Kaspi.kz	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Life360 has a net margin of 28.21% compared to Joint Stock Company Kaspi.kz's net margin of 24.89%. Joint Stock Company Kaspi.kz's return on equity of 43.80% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Joint Stock Company Kaspi.kz	24.89%	43.80%	10.03%
Life360	28.21%	6.80%	3.65%

32.2% of Joint Stock Company Kaspi.kz shares are held by institutional investors. Comparatively, 20.0% of Life360 shares are held by institutional investors. 6.8% of Life360 shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Joint Stock Company Kaspi.kz has higher revenue and earnings than Life360. Joint Stock Company Kaspi.kz is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint Stock Company Kaspi.kz	$7.70B	2.14	$2.04B	$10.84	7.98
Life360	$489.48M	9.15	$150.83M	$1.73	31.96

Joint Stock Company Kaspi.kz has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Life360 has a beta of 2.63, meaning that its stock price is 163% more volatile than the broader market.

Summary

Life360 beats Joint Stock Company Kaspi.kz on 10 of the 17 factors compared between the two stocks.

How does Life360 compare to Medpace?

Medpace (NASDAQ:MEDP) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
Life360	28.21%	6.80%	3.65%

Medpace currently has a consensus target price of $467.08, suggesting a potential downside of 12.35%. Life360 has a consensus target price of $64.17, suggesting a potential upside of 16.04%. Given Life360's stronger consensus rating and higher possible upside, analysts plainly believe Life360 is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

78.0% of Medpace shares are held by institutional investors. Comparatively, 20.0% of Life360 shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 6.8% of Life360 shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.01	$451.12M	$15.91	33.49
Life360	$489.48M	9.15	$150.83M	$1.73	31.96

In the previous week, Life360 had 8 more articles in the media than Medpace. MarketBeat recorded 11 mentions for Life360 and 3 mentions for Medpace. Medpace's average media sentiment score of 0.98 beat Life360's score of 0.44 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Medpace has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Life360 has a beta of 2.63, meaning that its stock price is 163% more volatile than the broader market.

Summary

Medpace beats Life360 on 9 of the 17 factors compared between the two stocks.

How does Life360 compare to Rentokil Initial?

Life360 (NASDAQ:LIF) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Life360 has a net margin of 28.21% compared to Rentokil Initial's net margin of 0.00%. Life360's return on equity of 6.80% beat Rentokil Initial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Rentokil Initial	N/A	N/A	N/A

20.0% of Life360 shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 6.8% of Life360 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Rentokil Initial has higher revenue and earnings than Life360.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	9.15	$150.83M	$1.73	31.96
Rentokil Initial	$6.91B	2.09	$470M	N/A	N/A

Life360 has a beta of 2.63, meaning that its share price is 163% more volatile than the broader market. Comparatively, Rentokil Initial has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

In the previous week, Life360 had 11 more articles in the media than Rentokil Initial. MarketBeat recorded 11 mentions for Life360 and 0 mentions for Rentokil Initial. Life360's average media sentiment score of 0.44 beat Rentokil Initial's score of 0.00 indicating that Life360 is being referred to more favorably in the media.

Company	Overall Sentiment
Life360	Neutral
Rentokil Initial	Neutral

Life360 currently has a consensus target price of $64.17, suggesting a potential upside of 16.04%. Rentokil Initial has a consensus target price of $34.50, suggesting a potential upside of 20.95%. Given Rentokil Initial's higher probable upside, analysts clearly believe Rentokil Initial is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Rentokil Initial	2 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Life360 beats Rentokil Initial on 10 of the 14 factors compared between the two stocks.

How does Life360 compare to Grab?

Life360 (NASDAQ:LIF) and Grab (NASDAQ:GRAB) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

Grab has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	9.15	$150.83M	$1.73	31.96
Grab	$3.37B	4.63	$268M	$0.01	380.50

Life360 presently has a consensus price target of $64.17, indicating a potential upside of 16.04%. Grab has a consensus price target of $6.23, indicating a potential upside of 63.67%. Given Grab's stronger consensus rating and higher possible upside, analysts plainly believe Grab is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Grab	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91

In the previous week, Grab had 1 more articles in the media than Life360. MarketBeat recorded 12 mentions for Grab and 11 mentions for Life360. Grab's average media sentiment score of 0.63 beat Life360's score of 0.44 indicating that Grab is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Grab	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.0% of Life360 shares are held by institutional investors. Comparatively, 55.5% of Grab shares are held by institutional investors. 6.8% of Life360 shares are held by company insiders. Comparatively, 3.6% of Grab shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Life360 has a net margin of 28.21% compared to Grab's net margin of 10.67%. Life360's return on equity of 6.80% beat Grab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Grab	10.67%	5.79%	3.28%

Life360 has a beta of 2.63, meaning that its share price is 163% more volatile than the broader market. Comparatively, Grab has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Summary

Grab beats Life360 on 9 of the 16 factors compared between the two stocks.

How does Life360 compare to Toast?

Life360 (NASDAQ:LIF) and Toast (NYSE:TOST) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

20.0% of Life360 shares are owned by institutional investors. Comparatively, 82.9% of Toast shares are owned by institutional investors. 6.8% of Life360 shares are owned by company insiders. Comparatively, 10.0% of Toast shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Toast	6.39%	20.86%	13.84%

Life360 presently has a consensus target price of $64.17, indicating a potential upside of 16.04%. Toast has a consensus target price of $37.62, indicating a potential upside of 34.51%. Given Toast's stronger consensus rating and higher probable upside, analysts plainly believe Toast is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Toast	0 Sell rating(s)	8 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.78

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	9.15	$150.83M	$1.73	31.96
Toast	$6.45B	2.24	$342M	$0.65	43.02

Life360 has a beta of 2.63, indicating that its stock price is 163% more volatile than the broader market. Comparatively, Toast has a beta of 1.76, indicating that its stock price is 76% more volatile than the broader market.

In the previous week, Life360 had 6 more articles in the media than Toast. MarketBeat recorded 11 mentions for Life360 and 5 mentions for Toast. Life360's average media sentiment score of 0.44 beat Toast's score of 0.42 indicating that Life360 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Toast	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Toast beats Life360 on 11 of the 17 factors compared between the two stocks.

Get Life360 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LIF vs. The Competition

Export

Metric	Life360	PROTECTION Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$4.48B	$3.35B	$9.80B	$12.58B
Dividend Yield	N/A	1.84%	3.53%	6.21%
P/E Ratio	31.93	21.79	25.86	24.86
Price / Sales	9.15	4.23	4,812.02	117.20
Price / Cash	N/A	27.30	27.38	36.96
Price / Book	7.91	3.45	4.66	6.58
Net Income	$150.83M	$106.44M	$791.01M	$336.70M
7 Day Performance	17.80%	2.42%	0.30%	3.29%
1 Month Performance	30.14%	-8.12%	-0.94%	1.72%
1 Year Performance	-15.26%	-20.17%	21.64%	31.91%

Life360 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LIF Life360	3.8665 of 5 stars	$55.55 -3.5%	$64.17 +15.5%	-7.3%	$4.49B	$489.48M	32.06	600	Gap Down
KSPI Joint Stock Company Kaspi.kz	3.9921 of 5 stars	$89.08 +2.6%	$96.67 +8.5%	+1.5%	$16.99B	$4.29T	8.25	14,008
MEDP Medpace	2.1986 of 5 stars	$524.52 +0.9%	$467.08 -11.0%	+72.1%	$15.03B	$2.68B	33.08	6,200
RTO Rentokil Initial	3.087 of 5 stars	$28.95 +0.2%	$34.50 +19.2%	+17.7%	$14.62B	$6.91B	N/A	63,388
GRAB Grab	4.1495 of 5 stars	$3.55 +2.7%	$6.19 +74.2%	-24.0%	$14.57B	$3.37B	355.86	12,012	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LIF) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Life360 (LIF) Competitors

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

How does Life360 compare to Joint Stock Company Kaspi.kz?

Summary

How does Life360 compare to Medpace?

Summary

How does Life360 compare to Rentokil Initial?

Summary

How does Life360 compare to Grab?

Summary

How does Life360 compare to Toast?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Life360 (LIF) Competitors

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

How does Life360 compare to Joint Stock Company Kaspi.kz?

Do analysts prefer KSPI or LIF?

Does the media prefer KSPI or LIF?

Is KSPI or LIF more profitable?

Do insiders & institutionals hold more shares of KSPI or LIF?

Which has stronger earnings & valuation, KSPI or LIF?

Which has more risk & volatility, KSPI or LIF?

Summary

How does Life360 compare to Medpace?

Is MEDP or LIF more profitable?

Do analysts rate MEDP or LIF?

Do institutionals & insiders believe in MEDP or LIF?

Which has stronger earnings and valuation, MEDP or LIF?

Does the media prefer MEDP or LIF?

Which has more volatility and risk, MEDP or LIF?

Summary

How does Life360 compare to Rentokil Initial?

Is LIF or RTO more profitable?

Do institutionals and insiders hold more shares of LIF or RTO?

Which has stronger valuation & earnings, LIF or RTO?

Which has more risk and volatility, LIF or RTO?

Does the media refer more to LIF or RTO?

Do analysts recommend LIF or RTO?

Summary

How does Life360 compare to Grab?

Which has preferable valuation and earnings, LIF or GRAB?

Do analysts prefer LIF or GRAB?

Does the media refer more to LIF or GRAB?

Do insiders & institutionals believe in LIF or GRAB?

Is LIF or GRAB more profitable?

Which has more volatility & risk, LIF or GRAB?

Summary

How does Life360 compare to Toast?

Do insiders and institutionals believe in LIF or TOST?

Is LIF or TOST more profitable?

Do analysts recommend LIF or TOST?

Which has stronger earnings and valuation, LIF or TOST?

Which has more risk & volatility, LIF or TOST?

Does the media favor LIF or TOST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools